[Federal Register Volume 62, Number 160 (Tuesday, August 19, 1997)]
[Notices]
[Page 44131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-21872]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Cooperative Agreements for Studies to Evaluate 
the Epidemiologic and Laboratory Characteristics of Human 
Immunodeficiency Virus (HIV) Infection Among United States Blood and 
Plasma Donors, Program Announcement 797: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Disease, Disability, and Injury Prevention and Control 
SEP: Cooperative Agreements for Studies to Evaluate the 
Epidemiologic and Laboratory Characteristics of Human 
Immunodeficiency Virus (HIV) Infection Among United States Blood and 
Plasma Donors, Program Announcement 797.
    Time and Date: 8:30 a.m.-5 p.m., September 9, 1997.
    Place: Executive Office Park, Building 16, Conference Room B, 16 
Executive Park Drive, Atlanta, Georgia 30329.
    Status: Closed.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement 797.
    The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., 
and the Determination of the Associate Director for Management and 
Operations, CDC, pursuant to Public Law 92-463.
    Contact Person for More Information: John R. Lehnherr, Chief, 
Prevention Support Office, National Center for HIV, STD, and TB 
Prevention, CDC, M/S E07, 1600 Clifton Road, NE, Atlanta, Georgia 
30333, telephone 404/639-8025.

    Dated: August 13, 1997.
Carolyn J. Russell,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention (CDC)
[FR Doc. 97-21872 Filed 8-18-97; 8:45 am]
BILLING CODE 4163-18-U